Luca Räss (Schlieren / CH), Liliana Malinovska (Schlieren / CH), Fabio Sabino (Schlieren / CH), Ino Karemaker (Schlieren / CH), Vytautas Iesmantavicius (Basel / CH), Roland Bruderer (Schlieren / CH), Lukas Reiter (Schlieren / CH)
Drug development faces a significant bottleneck due to the high failure rate of candidate drugs during clinical translation. Efficiently identifying drug targets and potential off-targets is crucial to address this challenge. Technologies such as limited proteolysis coupled with mass spectrometry (LiP-MS) aim to overcome this hurdle. LiP-MS offers a unique approach for unbiased drug target deconvolution and binding site identification in complex proteomes. However, current LiP-MS protocols remain challenging, low in throughput, and manual labor-intensive, which restricts their use in larger phenotypic screening for drug discovery. Here, we present the successful transfer of our current manual LiP-MS pipeline (based on LiP-Quant, Piazza et al. 2020) to a fully automated sample preparation workflow in combination with short gradient LC-MS methods.
Initially, we adapted our in-house manual LiP-MS sample preparation protocol to enhance its automation compatibility. Subsequently, we started automating the LiP-MS workflow by integrating the drug treatment and limited proteolysis step. Notably, the semi-automated method exhibited no discernible row- or column-wise trends, but it did yield a significant (~20%) reduction in the precursor coefficient of variation (CV) compared to the manual protocol. Furthermore, number of identified drug targets could be maintained in a benchmark experiment with the broad-spectrum kinase inhibitor staurosporine. Encouraged by these findings, we started to fully integrate the protocol, encompassing both up- and downstream processes of limited proteolysis, into our robotic system. The automated sample processing was integrated on a liquid handler which is robotically linked to various third-party devices such as an ultrasonicator, plate reader or positive pressure module. The integrated workflow allows the full sample preparation for a LiP-MS experiment including main processing steps of native cell lysis, drug dilution and treatment, limited proteolysis, proteolytic digestion, peptide clean-up, concentration determination and normalization. As a result, hands-on time decreased by over 70%, while data quality improved. Looking ahead, we plan to extend this assay to simultaneously screen several compounds in parallel.
To further improve the LiP-MS pipeline, the developed sample preparation was combined with a short-gradient dia-PASEF® LC-MS/MS measurement on the timsTOF HT mass spectrometer. We optimized the method for identification of both, semi-tryptic and tryptic peptides, using adjusted dia-PASEF window architecture and a non-linear gradient ramp. The final method with a gradient length of 45 minutes achieves a throughput of 24 samples per day, which reduces the acquisition time by 75% compared to our current method.
Taken together, by integrating automated sample preparation with short-gradient LC-MS, we achieved substantial improvements in our LiP-MS pipeline to make it suitable for larger drug screenings.
We use cookies on our website. Cookies are small (text) files that are created and stored on your device (e.g., smartphone, notebook, tablet, PC). Some of these cookies are technically necessary to operate the website, other cookies are used to extend the functionality of the website or for marketing purposes. Apart from the technically necessary cookies, you are free to allow or not allow cookies when visiting our website.